| Literature DB >> 21396097 |
Steffen Mickenautsch1, Veerasamy Yengopal.
Abstract
BACKGROUND: This article aims to update the existing systematic review evidence elicited by Mickenautsch et al. up to 18 January 2008 (published in the European Journal of Paediatric Dentistry in 2009) and addressing the review question of whether, in the same dentition and same cavity class, glass-ionomer cement (GIC) restored cavities show less recurrent carious lesions on cavity margins than cavities restored with amalgam.Entities:
Year: 2011 PMID: 21396097 PMCID: PMC3060833 DOI: 10.1186/1756-0500-4-58
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Quality assessment criteria of trials
| Selection bias | ||
|---|---|---|
| Randomisation and concealment | ||
| A | (i) Randomisation: Details of any adequate type of allocation method that generates random sequences with the patient as unit of randomisation are reported.1 | Doubts may still exist whether the trial results are influenced by selection bias but no indication can be found from the trial report to support such doubt. |
| B | (i) Randomisation: Details of any adequate type of allocation method that generates random sequences with the patient as unit of randomisation are reported.1 | Despite the implementation of method considered to be able to prevent unmasking of the concealed allocation sequence through direct observation and prediction, there are reasons to expect that the concealed allocation sequence may have been unmasked during the cause of the trial. |
| C | (i) Randomisation: Details of any adequate type of allocation method that generates random sequences with the patient as unit of randomisation are reported.1 | Despite the implementation of method considered to be able to prevent unmasking of the concealed allocation sequence through direct observation, there are reasons to expect that operators could have predicted the concealed allocation sequence. |
| D | (i) Randomisation: Details of any adequate type of allocation method that generates random sequences with the patient as unit of randomisation are reported.1 | Despite the theoretical chance for each patient to be allocated to either treatment group, operator knowledge of the allocation sequence may have lead to patient allocation that favoured the outcome of one type of treatment above the other. |
| 0 | Trial does not comply with criteria A - D. | No guaranty of equal chance for patients to be allocated to either treatment group, thus allocation may have favoured the outcome of one type of treatment above the other. |
| Baseline data for randomised trials | ||
| A | Baseline data collected before randomisation and reported for both treatment groups. Data shows no significant differences between both groups. | Evidence is given that randomisation has lead to equal groups suggesting little risk of selection bias. |
| B | Baseline data collected before randomisation and reported for both treatment groups. Data shows significant differences between both groups but has been statistically adjusted appropriately. | Differences have been adjusted, thus the influence of possible selection bias appears to be reduced. |
| C | Baseline data collected before randomisation and reported for both treatment groups. Data shows significant differences between both groups without being statistically adjusted. | Reported differences may be due to ineffective randomisation, thus indicate risk of selection bias. |
| 0 | Trial does not comply with criteria A - C. | No evidence is given whether randomisation has indeed lead to equal groups with differences beyond chance, thus differences may exists indicating selection bias. |
| Detection/Performance bias | ||
| Blinding/Masking | ||
| Score | Criteria | Impact on bias risk |
| A | (i) Trial reports on any type of method that is known to prevent patient AND operator AND evaluator to discern whether patients are allocated to the test- or the control group (Blinding/Masking). | Evidence is given that the trial results may not have been influenced by detection/performance bias that may have favored the outcome of one type of treatment above the other. |
| B | (i) Trial reports on any type of method that is known to prevent patient AND operator AND evaluator to discern whether patients are allocated to the test- or the control group (Blinding/Masking). | Doubts may still exist whether the trial results are influenced by detection/performance bias but no indication can be found from the trial report to support such doubt. However, no evaluation of the Blinding/Masking effect has been included in the trial, thus no evidence for lack of bias is given. |
| C | (i) Trial reports on any type of method that is known to prevent patient AND operator AND evaluator to discern whether patients are allocated to the test- or the control group (Blinding/Masking). | Despite the implementation of method considered to be able to prevent unmasking, there are reasons to expect that operators/patients could have discovered the allocation. |
| 0 | No process reported or implemented able to blind/mask patients AND operators whether patients where allocated to either the test- or the control group (It is insufficient to report that blinding/masking was done without reporting the details of the process). | Knowledge about the patient allocation may have caused patients/operator to act in a way that may have favoured the outcome of one type of treatment above the other, |
| Attrition bias | ||
| Loss - to follow up | ||
| Score | Criteria | Impact on bias risk |
| A | Available case analysis, loss-to-follow up reported per treatment group. Subsequent sensitivity analysis does not indicate a possible risk of bias. | The trial allows extracting evidence that attrition may not have favoured the outcome of one type of treatment above the other. |
| B | Available case analysis, loss-to-follow up reported per treatment group. Subsequent sensitivity analysis indicates a possible risk of bias. | The trial allows assessing the risk that attrition may have favoured the outcome of one type of treatment above the other. |
| 0 | Trial does not report number of included participants per treatment group at baseline or gives any indication that would allow ascertaining the loss-to-follow up rate per treatment group. | The trial carries an unknown risk that attrition may have favoured the outcome of one type of treatment above the other. |
| Run-in phase | ||
| A | No run-in phase reported or discernable during which patients were given the active treatment or the placebo/control. | The trial may not carry the risk of bias due to exclusion of patients who would not respond well to e.g. the active treatment. |
| 0 | Run-in phase reported or discernable during which patients were given the active treatment or the placebo/control. | During a run-in phase only patients were selected for randomisation that have responded/not responded to the active treatment of the placebo/control. This may favour the outcome of one type of treatment above the other as patients who did not respond well to either are excluded. |
| Trial endpoints | ||
| 0 | The trial reports on secondary or surrogate outcomes as endpoints. | Even if the surrogate results would highly correlate with primary (i.e. clinical) outcomes, they cannot serve as valid replacements and need to be regarded for hypothesis development, only. |
| A | The trial reports on primary outcomes as endpoints. | Primary outcomes may provide evidence for hypothesis testing. |
1 Excluded are types of allocation methods that are considered as inadequate: cluster randomisation, fixed block randomisation with block size 2, minimisation, alternation, randomisation of teeth, use of date of birth or patient record number, "quasi"-randomisation, split-mouth
2 E.g. by reporting results of the Berger-Exner Test or any other statistical tests that show that covariates of compared groups were similar at baseline
3 E.g. by opening of opaque envelope, obtaining allocation from tables, computer generated or from other sources
4 E.g. central randomisation, sequence allocation by other than operator; excluding varied block randomisation
Figure 1Flow diagram of trial selection. N = Number of trials; DS = Dataset number.
Excluded trials with reasons for exclusion
| Article | Reason for exclusion |
|---|---|
| Hickel and Voss, 1990 [ | Does not report on caries as trial outcome |
| Frencken et al., 2006 [ | Does not report on caries as trial outcome |
| Smith et al., 1990 [ | Does not report on caries as trial outcome |
| Smales et al., 1990 [ | Does not report on caries as trial outcome |
| Yip et al., 2002 [ | Does not report on caries as trial outcome |
| Phantumvanit et al., 1996 [ | No computable data reported: Does not report on number of same type of units for caries (tooth surfaces) as total number of evaluated units (restored teeth), baseline number of units |
| Rahimtoola and van Amerongen, 2002 [ | No computable data reported: Does not report on number of evaluated GIC/Amalgam restorations |
| Taifour et al., 2003 [ | No computable data reported: Does not report on number of baseline, restorations, number of evaluated restorations, number of restorations with caries (GIC/Amalgam) |
| Qvist et al., 2004 [ | No computable data reported: Does not report on number loss-to-follow up restorations per GIC/Amalgam |
| Rahimtoola and van Amerongen, 1997 [ | Published study protocol-no results reported |
| Mjör and Jokstad, 1993 [ | No computable data reported: Number of carious teeth not reported as quantitative units per GIC/Amalgam |
GIC = Glass-ionomer cement.
Details of accepted trials
| Article | DS | Patient character-istics/potential confounders* | GIC treatment group | Amalgam treatment group | Outcome measure | Evaluation | Dentition/Teeth/Restoration | Study period | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type of material | BSL | N | n | LTF | Type of material | BSL | N | n | LTF | Criteria | Method | ||||||
| Welbury et al., 1991 [ | 01 | [1] | Ketac Fil | 119 | 51 | 7 | 68 | Amalcap | 119 | 51 | 11 | 68 | Recurrent caries | USPHS | Clinical examination | Primary/Molars/Class I & II | 5 years |
| Östlund et al., 1992 [ | 02 | [2] | Chem Fil | 25 | 10 | 0 | 15 | ANA 2000 | 25 | 23 | 1 | 2 | Recurrent caries | USPHS | Clinical examination | Primary/Molars/Class II | 3 years |
| Taifour et al., 2002 [ | 03 | [3] | Fuji IX/ | 610 | 475 | 9 | 135 | Avalloy | 425 | 331 | 11 | 94 | Caries on margin | ART | Clinical examination | Primary/Molars/Single surface | 3 years |
| 04 | 478 | 106 | 4 | 372 | 380 | 84 | 9 | 296 | Primary/Molars/Multiple surface | ||||||||
| Mandari et al., 2003 [ | 05 | [4] | Fuji II | 223 | 173 | 3 | 50 | ANA 2000 | 207 | 162 | 16 | 45 | Recurrent caries | Modified USPHS | Clinical examination | Permanent/Molars/Single surface | 6 years |
| Frencken et al., 2007 [ | 06 | [5] | Fuji IX/ | 487 | 153 | 11 | 334 | Avalloy | 403 | 108 | 15 | 295 | Caries on margin | ART | Clinical examination | Permanent/Molars/Single surface | 6.3 years |
| Daou et al., 2009 [ | 07 | [6] | Fuji IX | 35 | 33 | 4 | 2 | Permite C | 38 | 36 | 1 | 2 | Recurrent caries | USPHS | Clinical examination | Primary/Molars/Class I & II | 1 year |
| 08 | 35 | 23 | 3 | 12 | 38 | 21 | 3 | 17 | 2 years | ||||||||
| Mandari et al., 2001 [ | 09 | [7] | Fuji II | 223 | 211 | 9 | 12 | ANA 2000 | 207 | 196 | 15 | 11 | Recurrent caries | Modified USPHS | Clinical examination | Permanent/Molars/Single surface | 2 years |
| Yu et al., 2004 [ | 10 | [8] | Fuji IX/ | 45 | 37 | 0 | 8 | GK amalgam | 32 | 23 | 0 | 9 | Recurrent caries | ART | Clinical examination | Primary/Molars/Single surface | 1 year |
| 11 | 45 | 29 | 0 | 16 | 32 | 18 | 0 | 14 | 2 years | ||||||||
| Svanberg, 1992 [ | 12 | [9] | Ketac Silver | 18 | 14 | 0 | 4 | Disper-salloy | 18 | 14 | 3 | 4 | Recurrent caries | SNBHW | Clinical examination | Permanent/Molars & Premolars/GIC = Tunnel/Amalgam = Class II | 3 years |
| 13 | 11 | 11 | 3 | 0 | 11 | 11 | 9 | 0 | Caries progression | Probing & Bitewing | Permanent/approximal adjacent surfaces | ||||||
| Qvist et al., 1997 [ | 14 | [10] | Ketac Fil | 515 | 334 | 11 | 181 | Disper-salloy | 543 | 306 | 17 | 237 | Recurrent caries | DPDHS | Clinical examination | Primary/Class I, II and III/V | 3 years |
| 15 | 127 | 105 | 25 | 22 | 127 | 94 | 47 | 33 | Caries progression | Primary & permanent/approximal adjacent surfaces (sound or arrested caries) | |||||||
| 16 | 156 | 120 | 25 | 36 | 183 | 129 | 47 | 54 | Caries progression | Primary/approximal adjacent surfaces (carious or active lesion) | |||||||
| 17 | 156 | 120 | 66 | 36 | 183 | 129 | 78 | 54 | No caries regression | Primary/approximal adjacent surfaces (carious or active lesion) | |||||||
DS = Dataset number; BSL = Number of teeth at baseline; N = Number of teeth evaluated; n = Number of teeth with caries, LTF = Loss-to-follow-up; USPHS = United States Public Health Service criteria; ART = Criteria for atraumatic restorative treatment; SNBHW = Criteria according to the Swedish National Board for Health and Welfare; DPHS = Danish Public Dental Health Service criteria.
* Potential confounders = Reported fluoride exposure; high-sugary diet; poor oral hygiene; high past caries experience.
Patient characteristics:
[1] Split-mouth trial. 76 patients, age 5 - 11 years; patients attending the Department of Child Dental Health at Newcastle Dental Hospital (UK) for routine restorative care; subjects were admitted to the trials if they required at least 1 pair of restorations in their deciduous molar dentition; paired cavities either Class I or II, if possible in the same tooth type; restoration always in different quadrants per pair; any cavity was suitable for inclusion; a cavity was excluded if it could only be satisfactory restored using a stainless steel crown; restorations placed between October 1982 and March 1987;caries removal by drill.
Potential confounders reported: none.
[2] Partial split-mouth trial. 56 patients, age 4-6 years regularly treated at one Public Dental Service clinic in Jönköping, Sweden who showed manifest caries lesion on the mesial surface of a 2nd primary molar; lesion not atypical or extended into buccal or lingual tooth surfaces; lesion completely surrounded by healthy enamel and should not reach the pulp; caries removal by drill;
Potential confounders reported: none.
[3] Parallel group trial. 835 patients, age 6-7 years from Damascus, Syria; with dentinal lesions with an opening wide enough for the smallest excavator to enter (diameter = 0.9 mm, without pulp involvement; size of restorations varied from small to large; dental caries prevalence 85%; mean dmfts and dmft scores of molars plus canines 9.0 and 4.4, respectively; GIC restorations placed after caries removal by hand excavation (ART).
Potential confounders reported: High past caries experience.
[4] Split-mouth trial. 152 patients from a cohort of grade 3-5 pupils, mean age 11 years in need of 2 or more restorations; from urban and rural schools near Dar es Salaam, Tanzania; selection criteria concerned dentine lesions in the occlusal surface that showed no evidence of pulpal involvement; pupils needed to have a dentine lesion present in contralateral permanent molars; infected dentine was removed with slow-speed drill and excavators or by hand excavation with use of Caridex.
Potential confounders reported: none.
[5] Parallel group trial. A total of 108 children of the ART group (GIC) and 84 children of the amalgam group were examined at evaluation year 6.3 - from Damascus, Syria; mean age 13.8 years; high risk for dentine lesion development (mean DMFT score 5.5); the mean DMFT and DMFS scores of the children in the ART group were 5.5 (SD 3.0) and 8.2 (SD 5.4) respectively; the mean DMFT and DMFS scores of the children in the amalgam group were 6.0 (SD 1/4 3.3) and 9.4 (SD 6.4); there was no statistically significant difference in caries scores between the children of the two groups (P > 0.05); the mean plaque score for the children in the ART and amalgam group were 1.3 (SD 0.58) and 1.2 (SD 0.52), respectively (see also [3]).
Potential confounders reported: Poor oral hygiene; high past caries experience.
[6] Partial split-mouth trial. 45 girls 6-8 years old from a private school (boarding and regular school) in Beirut, Lebanon; from a low socio-economic background with their first and second primary molars requiring new Class I or Class II restorations; specific criteria included vital teeth with normal appearance and morphology, and teeth with or without adjacent teeth; the children routinely (before and during study) received information and instructions to improve their oral hygiene, and had two dental examinations per year; criteria for exclusion from the study: patients having behavioural problems, patients with general health problems, patients with poor oral hygiene, molars requiring pulpotomy or pulpectomy; caries removal with drill;
Potential confounders reported: none.
[7] Split-mouth trial. see [4]
[8] Split-mouth trial. 60 Chinese children with mean age 7.4 (SD 1.24) years; 27 boys, 33 girls in Bejing; caries removal for GIC (ART) restorations by hand excavation or drill.
Potential confounders reported: none.
[9] Split-mouth trial. 18 caries-active patients, aged 13-16 years; from the regular clientele visiting one of the dental clinics of the Public Dental Health Service in Kronoberg, Sweden; with proximal primary, early carious lesions on contralateral posterior teeth needed restorative treatment; lesion extending into dentin; have progressed into deeper zone since preceding information; caries removal by drill.
Potential confounders reported: none.
[10] Partial split-mouth trial. 666 children, from 3 to 13 years of age within the Danish Public Dental Health Service in the municipalities of Vaerløse and Hillerød, Denmark. The caries experience among children and adolescents in the two municipalities is below the national average; caries removal by drill.
Potential confounders reported: Low past caries experience
Results of individual datasets
| Article | DS | RR | 95% CI | p-value |
|---|---|---|---|---|
| Welbury et al., 1991 [ | 01 | 0.64 | 0.27 - 1.51 | 0.31 |
| Östlund et al., 1992 [ | 02 | 0.73 | 0.03 - 16.47 | 0.84 |
| Taifour et al., 2002 [ | 03 | 0.57 | 0.24 - 1.36 | 0.21 |
| 04 | 0.35 | 0.11 - 1.10 | 0.07 | |
| Mandari et al., 2003 [ | 05 | 0.18 | 0.05 - 0.59 | 0.005* |
| Frencken et al., 2007 [ | 06 | 0.52 | 0.25 - 1.08 | 0.08 |
| Daou et al., 2009 [ | 07 | 4.36 | 0.51 - 37.09 | 0.18 |
| 08 | 0.91 | 0.21 - 4.04 | 0.90 | |
| Mandari et al., 2001 [ | 09 | 0.56 | 0.25 - 1.24 | 0.15 |
| Yu et al., 2004 [ | 10 | Not estimable | ||
| 11 | Not estimable | |||
| Svanberg, 1992 [ | 12 | 0.14 | 0.01 - 2.53 | 0.18 |
| 13 | 0.33 | 0.12 - 0.91 | 0.03* | |
| Qvist et al., 1997 [ | 14 | 0.59 | 0.28 - 1.25 | 0.17 |
| 15 | 0.48 | 0.32 - 0.71 | 0.0003* | |
| 16 | 0.57 | 0.38 - 0.87 | 0.0009* | |
| 17 | 0.91 | 0.73 - 1.13 | 0.38 | |
DS = Dataset number; RR = Relative risk; CI = Confidence interval; Not estimable = data from both treatment groups are essentially the same: p = 1.00.
* Statistically significant difference, in favour of GIC.
Figure 2Forrest plot of meta-analysis results concerning caries on margins of single-surface restorations in permanent teeth after 6 years. Study or sub-category = Dataset number; GIC = Glass-ionomer cement; RR = Relative Risk; CI = Confidence Interval; n = number of teeth with caries on restoration margins; N = Total number of evaluated teeth.
Figure 3Forrest plot of meta-analysis results concerning caries on margins of multiple-surface restorations in primary teeth after 3 years. Study or sub-category = Dataset number; GIC = Glass-ionomer cement; RR = Relative Risk; CI = Confidence Interval; n = number of teeth with caries on restoration margins; N = Total number of evaluated teeth.
Figure 4Forrest plot of cumulative meta-analysis results concerning caries on restoration margins in primary teeth (single- and multiple surface restorations combined). RR = Relative Risk; MH = Mantel-Haenszel weight.
Results of quality assessment of accepted trials
| Article | DS | Selection bias | Detection/Performance bias | Attrition bias | Trial outcome | ||
|---|---|---|---|---|---|---|---|
| Randomisation | Baseline data | Blinding/Masking | Loss-to-follow up | Run-in phase | |||
| Welbury et al., 1991 [ | 01 | 0 | 0 | 0 | A | A | A |
| Östlund et al., 1992 [ | 02 | 0 | 0 | 0 | B | A | A |
| Taifour et al., 2002 [ | 03 | 0 | A | 0 | A | A | A |
| 04 | 0 | A | 0 | A | A | A | |
| Mandari et al., 2003 [ | 05 | 0 | 0 | 0 | B | A | A |
| Frencken et al., 2007 [ | 06 | 0 | A | 0 | A | A | A |
| Daou et al., 2009 [ | 07 | 0 | 0 | 0 | A | A | A |
| 08 | 0 | 0 | 0 | A | A | A | |
| Mandari et al., 2001 [ | 09 | 0 | 0 | 0 | B | A | A |
| Yu et al., 2004 [ | 10 | 0 | 0 | 0 | A | A | A |
| 11 | 0 | 0 | 0 | A | A | A | |
| Svanberg, 1992 [ | 12 | 0 | 0 | 0 | A | A | A |
| 13 | 0 | 0 | 0 | A | A | 0 | |
| Qvist et al., 1997 [ | 14 | 0 | 0 | 0 | B | A | A |
| 15 | 0 | 0 | 0 | A | A | 0 | |
| 16 | 0 | 0 | 0 | A | A | 0 | |
| 17 | 0 | 0 | 0 | A | A | 0 | |
DS = Dataset number.
Figure 5Funnel plot of dataset results (test for publication bias). RR = Relative Risk.